Bharat Bhandari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bharat Bhandari has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Larry D. Scott
Gastroenterology and Hepatology, University of Texas Health Science Center, Houston, Texas, USA
2 shared publications- Soma Jyothula
Methodist Heart & Lung Institute, Methodist Hospital, San Antonio, TX
2 shared publications - Tejas Kirtane
Gastroenterology and Hepatology, University of Texas Health Science Center, Houston, Texas, USA
2 shared publications - Akshita Jain
North DMC Medical College and Hindu Rao Hospital, Delhi 110005, India
1 shared publication Bhairab Kumar Hamal
Department of Surgery, Shree Birendra Hospital and Nepalese Army Institute of Health Sciences, Kathmandu
1 shared publication- Bruce Fernando Sabath
Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
1 shared publication
Latest Publications
- Open Access
- 30 May 2024
- Published by MDPI AG in Journal of Respiration
- Vol. 4 (2) , 128-139
Robotic Bronchoscopy: A Comprehensive Review
Lung cancer, a major global cause of cancer-related deaths, demands continual advancements in diagnostic methodologies. This review delves into the transformative role of Robotic-Assisted Bronchoscopy (RAB) in redefining lung cancer diagnostics. As lung cancer screenings intensify, leading to a surge in pulmonary nodule diagnoses, navigational bronchoscopy, notably electromagnetic navigational bronchoscopy (ENB), faces persistent limitations. Examining key RAB platforms—Monarch™, Ion™ and the Galaxy System™—reveals their distinctive features, with RAB demonstrating superior diagnostic yields over traditional biopsy methods. However, challenges include CT-to-body divergence (CBCT) and divergent findings in diagnostic yield studies and a lack of head-to-head comparisons with non-RAB modalities. Future directions should explore RAB’s potential therapeutic applications, shaping the landscape of both diagnostics and therapeutics in lung cancer management.
- 30 May 2024
- Published by MDPI AG in Journal of Respiration
- Vol. 4 (2) , 128-139
Open AccessRobotic Bronchoscopy: A Comprehensive Review
Lung cancer, a major global cause of cancer-related deaths, demands continual advancements in diagnostic methodologies. This review delves into the transformative role of Robotic-Assisted Bronchoscopy (RAB) in redefining lung cancer diagnostics. As lung cancer screenings intensify, leading to a surge in pulmonary nodule diagnoses, navigational bronchoscopy, notably electromagnetic navigational bronchoscopy (ENB), faces persistent limitations. Examining key RAB platforms—Monarch™, Ion™ and the Galaxy System™—reveals their distinctive features, with RAB demonstrating superior diagnostic yields over traditional biopsy methods. However, challenges include CT-to-body divergence (CBCT) and divergent findings in diagnostic yield studies and a lack of head-to-head comparisons with non-RAB modalities. Future directions should explore RAB’s potential therapeutic applications, shaping the landscape of both diagnostics and therapeutics in lung cancer management.
- 13 October 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 219, 107426
Pulmonary manifestations of amyloidosis
- 13 October 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 219, 107426
Pulmonary manifestations of amyloidosis
- 23 May 2023
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 59 (7) , 452
An Unusual Case of Pulmonary Amyloidosis Causing Pleural Effusion Diagnosed With Medical Thoracoscopy
- 23 May 2023
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 59 (7) , 452
An Unusual Case of Pulmonary Amyloidosis Causing Pleural Effusion Diagnosed With Medical Thoracoscopy
- 20 February 2017
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 85 (6) , 1303-1304
Overtube-assisted pneumatic dilation for achalasia in megaesophagus
- 20 February 2017
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 85 (6) , 1303-1304
Overtube-assisted pneumatic dilation for achalasia in megaesophagus
- Open Access
- 1 December 2015
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 1 (2) , 19-22
Tamsulosin in the management of distal ureteric calculi
Introductions: Ureteral stones account for 20% urinary stone. Two third of ureteral stones are seen in lower third of ureter. Medical expulsive therapy is effective for such stones. This study was designed to observe the efficacy of ‘tamsulosin’ a selective alpha-1 adrenoreceptor antagonist in the management of lower ureteric stone. Methods: A cross sectional study of 70 cases of distal ureteral stones of sizes 5 to 10 mm was taken in the Department of Surgery of Shree Birendra Hospital, Nepalese Army Institute of Health Sciences (NAIHS) from January 2011 to 2013. Patients were randomly divided into tamsulosin and analgesic only groups. Stone expulsion at the end of three weeks was confirmed by X-ray or Ultrasonography. Results: Out of 70 patients, stone clearance rate in tamsulosin group was 28 in 35 cases (80%) and 21 in 35 cases (60%) in group II with analgesic only. The mean time of stone expulsion was 8.3 days in group I and 13.5 days in group II. Conclusions: In this study the use of tamsulosin in treatment of lower ureteral stones less than 10 mm was safe and effective.
- 1 December 2015
- Published by Nepal Journals Online (JOL) in Journal of Patan Academy of Health Sciences
- Vol. 1 (2) , 19-22
Open AccessTamsulosin in the management of distal ureteric calculi
Introductions: Ureteral stones account for 20% urinary stone. Two third of ureteral stones are seen in lower third of ureter. Medical expulsive therapy is effective for such stones. This study was designed to observe the efficacy of ‘tamsulosin’ a selective alpha-1 adrenoreceptor antagonist in the management of lower ureteric stone. Methods: A cross sectional study of 70 cases of distal ureteral stones of sizes 5 to 10 mm was taken in the Department of Surgery of Shree Birendra Hospital, Nepalese Army Institute of Health Sciences (NAIHS) from January 2011 to 2013. Patients were randomly divided into tamsulosin and analgesic only groups. Stone expulsion at the end of three weeks was confirmed by X-ray or Ultrasonography. Results: Out of 70 patients, stone clearance rate in tamsulosin group was 28 in 35 cases (80%) and 21 in 35 cases (60%) in group II with analgesic only. The mean time of stone expulsion was 8.3 days in group I and 13.5 days in group II. Conclusions: In this study the use of tamsulosin in treatment of lower ureteral stones less than 10 mm was safe and effective.